Immune effector cell associated neurotoxicity syndrome ICANS
Module 2: Toxicity Assessment and Management | ICANS
CAR-T Toxicities: CRS and ICANS
What is ICANS?
Treating CRS and ICANS: current approaches and future outlooks
Siltuximab for the management of CAR-T toxicities: a multicenter retrospective study
Management of CRS and ICANS after CAR-T therapy for ALL
Management of CAR-T related side effects
What are the management strategies for CRS and ICANS in MM?
Let’s Take a BiTE Out of CRS and Neurotoxicity - B. Kikani - 20231018
CAR T-cell toxicity: CRS, ICANS and prolonged cytopenias
CAR T-cell therapy: how can we improve toxicity management
Mechanisms and management of short- and long-term CAR-T toxicities
CAR T Cells: Beating Cancer with the Immune System
CAR-T and neurotoxicity: frequency and management
Nursing perspectives: a look at ICANS in CAR-T
Strategies to minimize the occurrence of CRS and ICANS in patients treated with CAR-T therapy
